E-LIB Suche - Ergebnisse für: Ishikawa, Kimi - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Bevacizumab suppressed degenerative changes in articular ca..:

Sotozawa, Masaichi ; Kumagai, Ken ; Ishikawa, Kimi...
Journal of Orthopaedic Surgery and Research. 18 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

2

Bevacizumab promotes tenogenic differentiation and maturati..:

Kusaba, Yohei ; Kumagai, Ken ; Ishikawa, Kimi...
PLOS ONE. 18 (2023) 10 - p. e0293463 , 2023

Link: https://doi.org/10.1371/..

3

AIRPLANE ACROBAT:

Ishikawa, Kimi , 2020

Link: https://search.ebscohost..

4

Bevacizumab suppressed degenerative changes in articular ca..:

Sotozawa, Masaichi ; Kumagai, Ken ; Ishikawa, Kimi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832671/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Effect of bevacizumab on toxicity:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.s004. , 2023

Link: https://doi.org/10.1371/..

6

Dose response test for VEGF administration to Tnmd:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.s005. , 2023

Link: https://doi.org/10.1371/..

7

Effects of VEGF on the expression of tenogenic differentiat..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.g002. , 2023

Link: https://doi.org/10.1371/..

8

Bevacizumab suppressed degenerative changes in articular ca..:

Masaichi Sotozawa ; Ken Kumagai ; Kimi Ishikawa...
https://doi.org/10.1186/s13018-023-03512-2. , 2023

Link: https://doi.org/10.1186/..

9

Bevacizumab promotes tenogenic differentiation and maturati..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617717/?tool=EBI. , 2023

Link: https://doaj.org/article..

10

Immunofluorescent staining of Tnmd:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.g004. , 2023

Link: https://doi.org/10.1371/..

11

Western blotting to investigate the effects of bevacizumab ..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.g005. , 2023

Link: https://doi.org/10.1371/..

12

Effect of bevacizumab on the migration:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.s003. , 2023

Link: https://doi.org/10.1371/..

13

Effects of bevacizumab on the expression of tenogenic diffe..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.g003. , 2023

Link: https://doi.org/10.1371/..

14

Expression of Tnmd in 2D-cultured TDCs treated with bevaciz..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
doi:10.1371/journal.pone.0293463.s006. , 2023

Link: https://doi.org/10.1371/..

15

Bevacizumab promotes tenogenic differentiation and maturati..:

Yohei Kusaba ; Ken Kumagai ; Kimi Ishikawa...
https://doi.org/10.1371/journal.pone.0293463. , 2023

Link: https://doi.org/10.1371/..

1-15